We also identified dermal gamma delta T (γδT) cells and IL-1 signaling as critical cellular and molecular mediators of AD-like inflammation downstream of Ovol1 deficiency-induced barrier dysregulation. The gene discussed is OVOL1; the disease is Alzheimer disease.